Science, politics, and values the politicization of professional practice guidelines

JAMA

Volumn 301, Issue 6, 2009, Pages 665-667

  Kraemer, John D ^a   Gostin, Lawrence O ^a  

^a GEORGETOWN UNIVERSITY LAW CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BORRELIA BURGDORFERI; CLINICAL FEATURE; ETHICS; HEALTH CARE POLICY; LONG TERM CARE; LYME DISEASE; MEDICAL SOCIETY; NOTE; POLITICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SCIENCE; ARTICLE; COMMUNICABLE DISEASE; LAW; LEGAL ASPECT; UNITED STATES;

ANTITRUST LAWS; COMMUNICABLE DISEASES; HEALTH POLICY; POLITICS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 60249085479     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.301.6.665     Document Type: Note

References (15)

1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
2. Feder HM Jr, Johnson BJ, O'Connell S, et al; Ad Hoc International Lyme Disease Group. A critical appraisal of "chronic Lyme disease" [correction published in N Engl J Med. 2008;358(10):1084]. N Engl J Med. 2007;357(14):1422-1430.
3. Cameron D, Gaito A, Harris N, et al; ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004; 2(1)(suppl):S1-S13.
4. Lyme disease treatment and prognosis. CDC Web site. http://www.cdc.gov/ ncidod/dvbid/lyme/ld-humandisease-treatment.htm. Updated October8, 2008. Accessed January 16, 2009.
5. Chronic Lyme disease. National Institute of Allergy and Infectious Diseases Web site. http://www3.niaid.nih.gov/topics/lymeDisease/understanding/ chronic.htm. Updated October 23, 2008. Accessed January 16, 2009.
6. Halperin JJ, Shapiro ED, Logigian E, et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69 (1):91-102.
7. Bowie WR. Guidelines for the management of Lyme disease: the controversy and the quandrary. Drugs. 2007;67(18):2661-2666.
8. Connecticut Attorney General's Office. Attorney General's investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter. http://www.ct.gov/AG/cwp/view.asp?A= 2795&Q=414284. Updated May 14, 2008. Accessed January 16, 2009.
9. IGeniX Inc Web site. http://igenex.com/Website. Accessed January 16, 2009.
10. LDA automated doctor referral system. Lyme Disease Association. http://www.lymediseaseassociation.org/referral/index.php. Accessed January 16, 2009.
11. Wilk v American Medical Association, 895 F2d 352 (7th Cir 1990).
12. Harris JL. Connecticut attorney general investigating possible anticompetitive impact of practice guidelines. ReedSmith Health Law Monitor. 2007;11(1): 2-4. http://www.reedsmith.com/-db/-documents/0704hlm.pdf. Accessed January 16, 2009.
13. Schachar v American Academy of Ophthalmology, Inc, 870 F2d 397 (7th Cir 1989).
14. Klein JO. Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease. Clin Infect Dis. 2008;47(9):1197-1199.
15. United States House of Representatives Committee on Government Reform-Minority Staff. Politics and Science in the Bush Administration. 2003. http://oversight.house.gov/features/politics-and-science/pdfs/pdf- politics-and-science-rep.pdf. Posted November 13, 2003. Accessed January 16, 2009.